330 related articles for article (PubMed ID: 22078793)
1. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.
Eiber M; Souvatzoglou M; Pickhard A; Loeffelbein DJ; Knopf A; Holzapfel K; Martinez-Möller A; Nekolla SG; Scherer EQ; Schwaiger M; Rummeny EJ; Beer AJ
Eur J Radiol; 2012 Oct; 81(10):2658-65. PubMed ID: 22078793
[TBL] [Abstract][Full Text] [Related]
2. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
3. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
4. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous reconstruction of activity and attenuation for PET/MR.
Salomon A; Goedicke A; Schweizer B; Aach T; Schulz V
IEEE Trans Med Imaging; 2011 Mar; 30(3):804-13. PubMed ID: 21118768
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients--current state of image quality.
Schwenzer NF; Stegger L; Bisdas S; Schraml C; Kolb A; Boss A; Müller M; Reimold M; Ernemann U; Claussen CD; Pfannenberg C; Schmidt H
Eur J Radiol; 2012 Nov; 81(11):3472-8. PubMed ID: 22260898
[TBL] [Abstract][Full Text] [Related]
7. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
8. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection?
Buchbender C; Hartung-Knemeyer V; Beiderwellen K; Heusch P; Kühl H; Lauenstein TC; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):877-82. PubMed ID: 23428414
[TBL] [Abstract][Full Text] [Related]
12. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance-based attenuation correction for PET/MR hybrid imaging using continuous valued attenuation maps.
Navalpakkam BK; Braun H; Kuwert T; Quick HH
Invest Radiol; 2013 May; 48(5):323-32. PubMed ID: 23442772
[TBL] [Abstract][Full Text] [Related]
15. Segmentation-based attenuation correction in positron emission tomography/magnetic resonance: erroneous tissue identification and its impact on positron emission tomography interpretation.
Brendle C; Schmidt H; Oergel A; Bezrukov I; Mueller M; Schraml C; Pfannenberg C; la Fougère C; Nikolaou K; Schwenzer N
Invest Radiol; 2015 May; 50(5):339-46. PubMed ID: 25585210
[TBL] [Abstract][Full Text] [Related]
16. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the attenuation properties of MR equipment for its use in a whole-body PET/MR scanner.
Delso G; Martinez-Möller A; Bundschuh RA; Ladebeck R; Candidus Y; Faul D; Ziegler SI
Phys Med Biol; 2010 Aug; 55(15):4361-74. PubMed ID: 20647598
[TBL] [Abstract][Full Text] [Related]
18. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
[TBL] [Abstract][Full Text] [Related]
19. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
[TBL] [Abstract][Full Text] [Related]
20. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]